Yong Loo Lin School of Medicine Research Excellence Award AY2018/2019
Feed-forward Regulatory Loop Driven by IRF4 and NF-kB in Adult T-cell Leukemia/Lymphoma.
DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells.
ASLAN003's potential for treating AML was discovered by research team from CSI Singapore and the National University Health System (NUHS).
Highlights from the 11th Frontiers in Cancer Science (FCS) conference which took place at The Academia @ SGH from 4 to 6 November 2019.
You can help us to shape the next generation of innovative cancer research
CSI Research Meeting
14 February @ 1.00pm
CeTM Lecture, Level 3, MD06
20 February 2020 - 2pm
#04-01 SMART Classroom
Epigenetics in Cancer Symposium 2020
2 - 3 March
CRC Audi, MD11
RNA Biology Symposium 2020
1 - 2 October 2020
Copyright © 2020 Cancer Science Institute of Singapore (CSI). All Rights Reserved.